|
|
|
|
830 Winter Street, Waltham, MA 02451 |
TEL: (781) 895-0600 FAX: (781) 895-0613 |
February 23, 2012
Via EDGAR
Securities and Exchange Commission
Division of Corporation Finance
100 F Street
Washington, DC 20549
|
Attn: |
Scot Foley, Staff Attorney |
|
|
|
|
Re: |
ImmunoGen, Inc. |
|
|
Form 10-K for the Fiscal Year Ended June 30, 2011 |
|
|
Filed August 29, 2011 |
|
|
Form 10-Q for the Quarterly Period Ended December 31, 2011 |
|
|
Filed January 31, 2012 |
|
|
File No. 000-17999 |
Ladies and Gentlemen:
This letter relates to comments from the staff (the “Staff”) of the Securities and Exchange Commission to ImmunoGen, Inc. (the “Company”) set forth in the Staff’s letter to the Company dated February 16, 2012 (the “Comment Letter”) regarding the above-referenced Company filings. The Company hereby confirms that it has (i) received the Comment Letter and (ii) will file its responses to the Comment Letter via EDGAR on or before March 16, 2012.
If you have any questions or comments regarding the Company’s anticipated timing for the submission of its responses, kindly contact the undersigned at (781) 895-0637 or our Corporate Controller, David Foster, at (781) 895-0765.
Sincerely,
/s/ Craig Barrows
Craig Barrows
Vice President, General Counsel and Secretary
|
cc: |
Jim B. Rosenberg, Senior Assistant Chief Accountant |
|
|
Ibolya Ignat, Staff Accountant |
|
|
Mark Brunhofer, Accounting Reviewer |